MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
This study has been completed.
Study NCT00462605
Information provided by National Cancer Institute (NCI)
First Received on April 18, 2007.
Last Updated on January 8, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
